Article Contents ::

Details About Generic Salt ::  Pyridoxi

Main Medicine Class:: Vitamin   

(peer-ih-DOX-een HIGH-droe-KLOR-ide)
Aminoxin, Nestrex,  Hexa-Betalin
Class: Vitamin

 

Action Vitamin B6 functions as coenzyme in amino acid, carbohydrate and lipid metabolism.

 

Indications Pyridoxine deficiency, including inadequate diet, drug-induced causes (eg, isoniazid, hydralazine, oral contraceptives) or inborn errors of metabolism. Parenteral use is indicated when oral therapy is not feasible. Unlabeled use(s): Treatment of hydrazine poisoning, PMS, hyperoxaluria type I, nausea and vomiting in pregnancy, sideroblastic anemia associated with high serum iron, carpal tunnel syndrome, tardive dyskinesia.

 

Contraindications Standard considerations.

 

Route/Dosage

Dietary Deficiency

ADULTS: PO/IM/IV 10 to 20 mg/day for 3 wk.

Drug-Induced Deficiency Anemia or Neuritis

ADULTS: PO/IM/IV 100 to 200 mg/day for 3 wk; follow with 25 to 100 mg/day.

Neuropathy

ADULTS: PO/IM/IV 50 to 200 mg/day.

Vitamin B6 Dependency Syndrome

ADULTS: PO/IM/IV 600 mg, followed by 30 mg/day for life. Dependency has been noted in adults administered 200 mg/day. PYRIDOXINE-DEPENDENT INFANTS: IM/IV 10 to 100 mg, followed by 2 to 100 mg/day.

Metabolic Disorders

ADULTS: PO/IM/IV 100 to 500 mg/day.

Isoniazid (INH) Poisoning

ADULTS & CHILDREN: IV 4 gm IV followed by 1 gm IM q 30 min until pyridoxine dose equal to INH dose has been given.

 

Interactions

Cycloserine, INH, hydralazine, oral contraceptives, penicillamine: Increased need for pyridoxine. Levodopa: Decreased effect of levodopa. (Interaction does not occur with levodopa/carbidopa in combination with pyridoxine.) Phenytoin: Phenytoin serum levels may be decreased. Parenteral: INCOMPATIBILITIES: Incompatible with alkaline solutions, iron salts and oxidizing agents.

 

Lab Test Interferences May result in false-positive urobilinogen in the spot test using Ehrlich’s reagent.

 

Adverse Reactions

CNS: Neuropathy; unstable gait; drowsiness; somnolence. EENT: Perioral numbness. OTHER: Numbness of feet; decreased sensation to touch, temperature or vibration; paresthesia; low serum folic acid levels; burning/stinging at IM injection site; photoallergic reaction; ataxia.

 

Precautions

Pregnancy: Category A. (Category C in doses that exceed the RDA.) Lactation: Excreted in breast milk; may inhibit lactation. Children: Safety and efficacy not established in doses exceeding nutritional requirements.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • Instruct patient to swallow sustained-release preparation whole and not to break, crush or chew.
  • When giving via IM route, rotate sites.
  • IV preparation may be given undiluted or added to standard compatible IV solutions.
  • Store all forms of drug at room temperature in tightly-closed, light-resistant containers. Avoid freezing injection.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Assess for signs of vitamin B6 deficiency (eg, irritability, seizures, anemia, dermatitis, nausea, vomiting) prior to and during therapy.
  • Institute seizure precautions in pyridoxine-dependent infants.
  • Obtain dietary consultation to review importance of well-balanced meals and sources of B6 prior to discharge home.
OVERDOSAGE: SIGNS & SYMPTOMS
  Ataxia, sensory neuropathy

 

Patient/Family Education

  • Emphasize importance of complying with prescribed dietary recommendations.
  • Teach patient about foods high in B6 (whole grain cereals, meat [eg, liver,] potatoes, green vegetables, legumes [eg, lima beans], yeast and bananas).
  • If patient is self-medicating with vitamin supplements, caution that megadosing may cause side effects such as unsteady gait, impaired hand coordination and numbness of feet.

 

Drugs Class ::

(peer-ih-DOX-een HIGH-droe-KLOR-ide)
Aminoxin, Nestrex,  Hexa-Betalin
Class: Vitamin

 

Action Vitamin B6 functions as coenzyme in amino acid, carbohydrate and lipid metabolism.

 

Indications Pyridoxine deficiency, including inadequate diet, drug-induced causes (eg, isoniazid, hydralazine, oral contraceptives) or inborn errors of metabolism. Parenteral use is indicated when oral therapy is not feasible. Unlabeled use(s): Treatment of hydrazine poisoning, PMS, hyperoxaluria type I, nausea and vomiting in pregnancy, sideroblastic anemia associated with high serum iron, carpal tunnel syndrome, tardive dyskinesia.

 

Contraindications Standard considerations.

 

Route/Dosage

Dietary Deficiency

ADULTS: PO/IM/IV 10 to 20 mg/day for 3 wk.

Drug-Induced Deficiency Anemia or Neuritis

ADULTS: PO/IM/IV 100 to 200 mg/day for 3 wk; follow with 25 to 100 mg/day.

Neuropathy

ADULTS: PO/IM/IV 50 to 200 mg/day.

Vitamin B6 Dependency Syndrome

ADULTS: PO/IM/IV 600 mg, followed by 30 mg/day for life. Dependency has been noted in adults administered 200 mg/day. PYRIDOXINE-DEPENDENT INFANTS: IM/IV 10 to 100 mg, followed by 2 to 100 mg/day.

Metabolic Disorders

ADULTS: PO/IM/IV 100 to 500 mg/day.

Isoniazid (INH) Poisoning

ADULTS & CHILDREN: IV 4 gm IV followed by 1 gm IM q 30 min until pyridoxine dose equal to INH dose has been given.

 

Interactions

Cycloserine, INH, hydralazine, oral contraceptives, penicillamine: Increased need for pyridoxine. Levodopa: Decreased effect of levodopa. (Interaction does not occur with levodopa/carbidopa in combination with pyridoxine.) Phenytoin: Phenytoin serum levels may be decreased. Parenteral: INCOMPATIBILITIES: Incompatible with alkaline solutions, iron salts and oxidizing agents.

 

Lab Test Interferences May result in false-positive urobilinogen in the spot test using Ehrlich’s reagent.

 

Adverse Reactions

CNS: Neuropathy; unstable gait; drowsiness; somnolence. EENT: Perioral numbness. OTHER: Numbness of feet; decreased sensation to touch, temperature or vibration; paresthesia; low serum folic acid levels; burning/stinging at IM injection site; photoallergic reaction; ataxia.

 

Precautions

Pregnancy: Category A. (Category C in doses that exceed the RDA.) Lactation: Excreted in breast milk; may inhibit lactation. Children: Safety and efficacy not established in doses exceeding nutritional requirements.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • Instruct patient to swallow sustained-release preparation whole and not to break, crush or chew.
  • When giving via IM route, rotate sites.
  • IV preparation may be given undiluted or added to standard compatible IV solutions.
  • Store all forms of drug at room temperature in tightly-closed, light-resistant containers. Avoid freezing injection.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Assess for signs of vitamin B6 deficiency (eg, irritability, seizures, anemia, dermatitis, nausea, vomiting) prior to and during therapy.
  • Institute seizure precautions in pyridoxine-dependent infants.
  • Obtain dietary consultation to review importance of well-balanced meals and sources of B6 prior to discharge home.
OVERDOSAGE: SIGNS & SYMPTOMS
  Ataxia, sensory neuropathy

 

Patient/Family Education

  • Emphasize importance of complying with prescribed dietary recommendations.
  • Teach patient about foods high in B6 (whole grain cereals, meat [eg, liver,] potatoes, green vegetables, legumes [eg, lima beans], yeast and bananas).
  • If patient is self-medicating with vitamin supplements, caution that megadosing may cause side effects such as unsteady gait, impaired hand coordination and numbness of feet.

Indications for Drugs ::

(peer-ih-DOX-een HIGH-droe-KLOR-ide)
Aminoxin, Nestrex,  Hexa-Betalin
Class: Vitamin

 

Action Vitamin B6 functions as coenzyme in amino acid, carbohydrate and lipid metabolism.

 

Indications Pyridoxine deficiency, including inadequate diet, drug-induced causes (eg, isoniazid, hydralazine, oral contraceptives) or inborn errors of metabolism. Parenteral use is indicated when oral therapy is not feasible. Unlabeled use(s): Treatment of hydrazine poisoning, PMS, hyperoxaluria type I, nausea and vomiting in pregnancy, sideroblastic anemia associated with high serum iron, carpal tunnel syndrome, tardive dyskinesia.

 

Contraindications Standard considerations.

 

Route/Dosage

Dietary Deficiency

ADULTS: PO/IM/IV 10 to 20 mg/day for 3 wk.

Drug-Induced Deficiency Anemia or Neuritis

ADULTS: PO/IM/IV 100 to 200 mg/day for 3 wk; follow with 25 to 100 mg/day.

Neuropathy

ADULTS: PO/IM/IV 50 to 200 mg/day.

Vitamin B6 Dependency Syndrome

ADULTS: PO/IM/IV 600 mg, followed by 30 mg/day for life. Dependency has been noted in adults administered 200 mg/day. PYRIDOXINE-DEPENDENT INFANTS: IM/IV 10 to 100 mg, followed by 2 to 100 mg/day.

Metabolic Disorders

ADULTS: PO/IM/IV 100 to 500 mg/day.

Isoniazid (INH) Poisoning

ADULTS & CHILDREN: IV 4 gm IV followed by 1 gm IM q 30 min until pyridoxine dose equal to INH dose has been given.

 

Interactions

Cycloserine, INH, hydralazine, oral contraceptives, penicillamine: Increased need for pyridoxine. Levodopa: Decreased effect of levodopa. (Interaction does not occur with levodopa/carbidopa in combination with pyridoxine.) Phenytoin: Phenytoin serum levels may be decreased. Parenteral: INCOMPATIBILITIES: Incompatible with alkaline solutions, iron salts and oxidizing agents.

 

Lab Test Interferences May result in false-positive urobilinogen in the spot test using Ehrlich’s reagent.

 

Adverse Reactions

CNS: Neuropathy; unstable gait; drowsiness; somnolence. EENT: Perioral numbness. OTHER: Numbness of feet; decreased sensation to touch, temperature or vibration; paresthesia; low serum folic acid levels; burning/stinging at IM injection site; photoallergic reaction; ataxia.

 

Precautions

Pregnancy: Category A. (Category C in doses that exceed the RDA.) Lactation: Excreted in breast milk; may inhibit lactation. Children: Safety and efficacy not established in doses exceeding nutritional requirements.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • Instruct patient to swallow sustained-release preparation whole and not to break, crush or chew.
  • When giving via IM route, rotate sites.
  • IV preparation may be given undiluted or added to standard compatible IV solutions.
  • Store all forms of drug at room temperature in tightly-closed, light-resistant containers. Avoid freezing injection.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Assess for signs of vitamin B6 deficiency (eg, irritability, seizures, anemia, dermatitis, nausea, vomiting) prior to and during therapy.
  • Institute seizure precautions in pyridoxine-dependent infants.
  • Obtain dietary consultation to review importance of well-balanced meals and sources of B6 prior to discharge home.
OVERDOSAGE: SIGNS & SYMPTOMS
  Ataxia, sensory neuropathy

 

Patient/Family Education

  • Emphasize importance of complying with prescribed dietary recommendations.
  • Teach patient about foods high in B6 (whole grain cereals, meat [eg, liver,] potatoes, green vegetables, legumes [eg, lima beans], yeast and bananas).
  • If patient is self-medicating with vitamin supplements, caution that megadosing may cause side effects such as unsteady gait, impaired hand coordination and numbness of feet.

Drug Dose ::

(peer-ih-DOX-een HIGH-droe-KLOR-ide)
Aminoxin, Nestrex,  Hexa-Betalin
Class: Vitamin

 

Action Vitamin B6 functions as coenzyme in amino acid, carbohydrate and lipid metabolism.

 

Indications Pyridoxine deficiency, including inadequate diet, drug-induced causes (eg, isoniazid, hydralazine, oral contraceptives) or inborn errors of metabolism. Parenteral use is indicated when oral therapy is not feasible. Unlabeled use(s): Treatment of hydrazine poisoning, PMS, hyperoxaluria type I, nausea and vomiting in pregnancy, sideroblastic anemia associated with high serum iron, carpal tunnel syndrome, tardive dyskinesia.

 

Contraindications Standard considerations.

 

Route/Dosage

Dietary Deficiency

ADULTS: PO/IM/IV 10 to 20 mg/day for 3 wk.

Drug-Induced Deficiency Anemia or Neuritis

ADULTS: PO/IM/IV 100 to 200 mg/day for 3 wk; follow with 25 to 100 mg/day.

Neuropathy

ADULTS: PO/IM/IV 50 to 200 mg/day.

Vitamin B6 Dependency Syndrome

ADULTS: PO/IM/IV 600 mg, followed by 30 mg/day for life. Dependency has been noted in adults administered 200 mg/day. PYRIDOXINE-DEPENDENT INFANTS: IM/IV 10 to 100 mg, followed by 2 to 100 mg/day.

Metabolic Disorders

ADULTS: PO/IM/IV 100 to 500 mg/day.

Isoniazid (INH) Poisoning

ADULTS & CHILDREN: IV 4 gm IV followed by 1 gm IM q 30 min until pyridoxine dose equal to INH dose has been given.

 

Interactions

Cycloserine, INH, hydralazine, oral contraceptives, penicillamine: Increased need for pyridoxine. Levodopa: Decreased effect of levodopa. (Interaction does not occur with levodopa/carbidopa in combination with pyridoxine.) Phenytoin: Phenytoin serum levels may be decreased. Parenteral: INCOMPATIBILITIES: Incompatible with alkaline solutions, iron salts and oxidizing agents.

 

Lab Test Interferences May result in false-positive urobilinogen in the spot test using Ehrlich’s reagent.

 

Adverse Reactions

CNS: Neuropathy; unstable gait; drowsiness; somnolence. EENT: Perioral numbness. OTHER: Numbness of feet; decreased sensation to touch, temperature or vibration; paresthesia; low serum folic acid levels; burning/stinging at IM injection site; photoallergic reaction; ataxia.

 

Precautions

Pregnancy: Category A. (Category C in doses that exceed the RDA.) Lactation: Excreted in breast milk; may inhibit lactation. Children: Safety and efficacy not established in doses exceeding nutritional requirements.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • Instruct patient to swallow sustained-release preparation whole and not to break, crush or chew.
  • When giving via IM route, rotate sites.
  • IV preparation may be given undiluted or added to standard compatible IV solutions.
  • Store all forms of drug at room temperature in tightly-closed, light-resistant containers. Avoid freezing injection.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Assess for signs of vitamin B6 deficiency (eg, irritability, seizures, anemia, dermatitis, nausea, vomiting) prior to and during therapy.
  • Institute seizure precautions in pyridoxine-dependent infants.
  • Obtain dietary consultation to review importance of well-balanced meals and sources of B6 prior to discharge home.
OVERDOSAGE: SIGNS & SYMPTOMS
  Ataxia, sensory neuropathy

 

Patient/Family Education

  • Emphasize importance of complying with prescribed dietary recommendations.
  • Teach patient about foods high in B6 (whole grain cereals, meat [eg, liver,] potatoes, green vegetables, legumes [eg, lima beans], yeast and bananas).
  • If patient is self-medicating with vitamin supplements, caution that megadosing may cause side effects such as unsteady gait, impaired hand coordination and numbness of feet.

Contraindication ::

(peer-ih-DOX-een HIGH-droe-KLOR-ide)
Aminoxin, Nestrex,  Hexa-Betalin
Class: Vitamin

 

Action Vitamin B6 functions as coenzyme in amino acid, carbohydrate and lipid metabolism.

 

Indications Pyridoxine deficiency, including inadequate diet, drug-induced causes (eg, isoniazid, hydralazine, oral contraceptives) or inborn errors of metabolism. Parenteral use is indicated when oral therapy is not feasible. Unlabeled use(s): Treatment of hydrazine poisoning, PMS, hyperoxaluria type I, nausea and vomiting in pregnancy, sideroblastic anemia associated with high serum iron, carpal tunnel syndrome, tardive dyskinesia.

 

Contraindications Standard considerations.

 

Route/Dosage

Dietary Deficiency

ADULTS: PO/IM/IV 10 to 20 mg/day for 3 wk.

Drug-Induced Deficiency Anemia or Neuritis

ADULTS: PO/IM/IV 100 to 200 mg/day for 3 wk; follow with 25 to 100 mg/day.

Neuropathy

ADULTS: PO/IM/IV 50 to 200 mg/day.

Vitamin B6 Dependency Syndrome

ADULTS: PO/IM/IV 600 mg, followed by 30 mg/day for life. Dependency has been noted in adults administered 200 mg/day. PYRIDOXINE-DEPENDENT INFANTS: IM/IV 10 to 100 mg, followed by 2 to 100 mg/day.

Metabolic Disorders

ADULTS: PO/IM/IV 100 to 500 mg/day.

Isoniazid (INH) Poisoning

ADULTS & CHILDREN: IV 4 gm IV followed by 1 gm IM q 30 min until pyridoxine dose equal to INH dose has been given.

 

Interactions

Cycloserine, INH, hydralazine, oral contraceptives, penicillamine: Increased need for pyridoxine. Levodopa: Decreased effect of levodopa. (Interaction does not occur with levodopa/carbidopa in combination with pyridoxine.) Phenytoin: Phenytoin serum levels may be decreased. Parenteral: INCOMPATIBILITIES: Incompatible with alkaline solutions, iron salts and oxidizing agents.

 

Lab Test Interferences May result in false-positive urobilinogen in the spot test using Ehrlich’s reagent.

 

Adverse Reactions

CNS: Neuropathy; unstable gait; drowsiness; somnolence. EENT: Perioral numbness. OTHER: Numbness of feet; decreased sensation to touch, temperature or vibration; paresthesia; low serum folic acid levels; burning/stinging at IM injection site; photoallergic reaction; ataxia.

 

Precautions

Pregnancy: Category A. (Category C in doses that exceed the RDA.) Lactation: Excreted in breast milk; may inhibit lactation. Children: Safety and efficacy not established in doses exceeding nutritional requirements.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • Instruct patient to swallow sustained-release preparation whole and not to break, crush or chew.
  • When giving via IM route, rotate sites.
  • IV preparation may be given undiluted or added to standard compatible IV solutions.
  • Store all forms of drug at room temperature in tightly-closed, light-resistant containers. Avoid freezing injection.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Assess for signs of vitamin B6 deficiency (eg, irritability, seizures, anemia, dermatitis, nausea, vomiting) prior to and during therapy.
  • Institute seizure precautions in pyridoxine-dependent infants.
  • Obtain dietary consultation to review importance of well-balanced meals and sources of B6 prior to discharge home.
OVERDOSAGE: SIGNS & SYMPTOMS
  Ataxia, sensory neuropathy

 

Patient/Family Education

  • Emphasize importance of complying with prescribed dietary recommendations.
  • Teach patient about foods high in B6 (whole grain cereals, meat [eg, liver,] potatoes, green vegetables, legumes [eg, lima beans], yeast and bananas).
  • If patient is self-medicating with vitamin supplements, caution that megadosing may cause side effects such as unsteady gait, impaired hand coordination and numbness of feet.

Drug Precautions ::

(peer-ih-DOX-een HIGH-droe-KLOR-ide)
Aminoxin, Nestrex,  Hexa-Betalin
Class: Vitamin

 

Action Vitamin B6 functions as coenzyme in amino acid, carbohydrate and lipid metabolism.

 

Indications Pyridoxine deficiency, including inadequate diet, drug-induced causes (eg, isoniazid, hydralazine, oral contraceptives) or inborn errors of metabolism. Parenteral use is indicated when oral therapy is not feasible. Unlabeled use(s): Treatment of hydrazine poisoning, PMS, hyperoxaluria type I, nausea and vomiting in pregnancy, sideroblastic anemia associated with high serum iron, carpal tunnel syndrome, tardive dyskinesia.

 

Contraindications Standard considerations.

 

Route/Dosage

Dietary Deficiency

ADULTS: PO/IM/IV 10 to 20 mg/day for 3 wk.

Drug-Induced Deficiency Anemia or Neuritis

ADULTS: PO/IM/IV 100 to 200 mg/day for 3 wk; follow with 25 to 100 mg/day.

Neuropathy

ADULTS: PO/IM/IV 50 to 200 mg/day.

Vitamin B6 Dependency Syndrome

ADULTS: PO/IM/IV 600 mg, followed by 30 mg/day for life. Dependency has been noted in adults administered 200 mg/day. PYRIDOXINE-DEPENDENT INFANTS: IM/IV 10 to 100 mg, followed by 2 to 100 mg/day.

Metabolic Disorders

ADULTS: PO/IM/IV 100 to 500 mg/day.

Isoniazid (INH) Poisoning

ADULTS & CHILDREN: IV 4 gm IV followed by 1 gm IM q 30 min until pyridoxine dose equal to INH dose has been given.

 

Interactions

Cycloserine, INH, hydralazine, oral contraceptives, penicillamine: Increased need for pyridoxine. Levodopa: Decreased effect of levodopa. (Interaction does not occur with levodopa/carbidopa in combination with pyridoxine.) Phenytoin: Phenytoin serum levels may be decreased. Parenteral: INCOMPATIBILITIES: Incompatible with alkaline solutions, iron salts and oxidizing agents.

 

Lab Test Interferences May result in false-positive urobilinogen in the spot test using Ehrlich’s reagent.

 

Adverse Reactions

CNS: Neuropathy; unstable gait; drowsiness; somnolence. EENT: Perioral numbness. OTHER: Numbness of feet; decreased sensation to touch, temperature or vibration; paresthesia; low serum folic acid levels; burning/stinging at IM injection site; photoallergic reaction; ataxia.

 

Precautions

Pregnancy: Category A. (Category C in doses that exceed the RDA.) Lactation: Excreted in breast milk; may inhibit lactation. Children: Safety and efficacy not established in doses exceeding nutritional requirements.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • Instruct patient to swallow sustained-release preparation whole and not to break, crush or chew.
  • When giving via IM route, rotate sites.
  • IV preparation may be given undiluted or added to standard compatible IV solutions.
  • Store all forms of drug at room temperature in tightly-closed, light-resistant containers. Avoid freezing injection.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Assess for signs of vitamin B6 deficiency (eg, irritability, seizures, anemia, dermatitis, nausea, vomiting) prior to and during therapy.
  • Institute seizure precautions in pyridoxine-dependent infants.
  • Obtain dietary consultation to review importance of well-balanced meals and sources of B6 prior to discharge home.
OVERDOSAGE: SIGNS & SYMPTOMS
  Ataxia, sensory neuropathy

 

Patient/Family Education

  • Emphasize importance of complying with prescribed dietary recommendations.
  • Teach patient about foods high in B6 (whole grain cereals, meat [eg, liver,] potatoes, green vegetables, legumes [eg, lima beans], yeast and bananas).
  • If patient is self-medicating with vitamin supplements, caution that megadosing may cause side effects such as unsteady gait, impaired hand coordination and numbness of feet.

Drug Side Effects ::

(peer-ih-DOX-een HIGH-droe-KLOR-ide)
Aminoxin, Nestrex,  Hexa-Betalin
Class: Vitamin

 

Action Vitamin B6 functions as coenzyme in amino acid, carbohydrate and lipid metabolism.

 

Indications Pyridoxine deficiency, including inadequate diet, drug-induced causes (eg, isoniazid, hydralazine, oral contraceptives) or inborn errors of metabolism. Parenteral use is indicated when oral therapy is not feasible. Unlabeled use(s): Treatment of hydrazine poisoning, PMS, hyperoxaluria type I, nausea and vomiting in pregnancy, sideroblastic anemia associated with high serum iron, carpal tunnel syndrome, tardive dyskinesia.

 

Contraindications Standard considerations.

 

Route/Dosage

Dietary Deficiency

ADULTS: PO/IM/IV 10 to 20 mg/day for 3 wk.

Drug-Induced Deficiency Anemia or Neuritis

ADULTS: PO/IM/IV 100 to 200 mg/day for 3 wk; follow with 25 to 100 mg/day.

Neuropathy

ADULTS: PO/IM/IV 50 to 200 mg/day.

Vitamin B6 Dependency Syndrome

ADULTS: PO/IM/IV 600 mg, followed by 30 mg/day for life. Dependency has been noted in adults administered 200 mg/day. PYRIDOXINE-DEPENDENT INFANTS: IM/IV 10 to 100 mg, followed by 2 to 100 mg/day.

Metabolic Disorders

ADULTS: PO/IM/IV 100 to 500 mg/day.

Isoniazid (INH) Poisoning

ADULTS & CHILDREN: IV 4 gm IV followed by 1 gm IM q 30 min until pyridoxine dose equal to INH dose has been given.

 

Interactions

Cycloserine, INH, hydralazine, oral contraceptives, penicillamine: Increased need for pyridoxine. Levodopa: Decreased effect of levodopa. (Interaction does not occur with levodopa/carbidopa in combination with pyridoxine.) Phenytoin: Phenytoin serum levels may be decreased. Parenteral: INCOMPATIBILITIES: Incompatible with alkaline solutions, iron salts and oxidizing agents.

 

Lab Test Interferences May result in false-positive urobilinogen in the spot test using Ehrlich’s reagent.

 

Adverse Reactions

CNS: Neuropathy; unstable gait; drowsiness; somnolence. EENT: Perioral numbness. OTHER: Numbness of feet; decreased sensation to touch, temperature or vibration; paresthesia; low serum folic acid levels; burning/stinging at IM injection site; photoallergic reaction; ataxia.

 

Precautions

Pregnancy: Category A. (Category C in doses that exceed the RDA.) Lactation: Excreted in breast milk; may inhibit lactation. Children: Safety and efficacy not established in doses exceeding nutritional requirements.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • Instruct patient to swallow sustained-release preparation whole and not to break, crush or chew.
  • When giving via IM route, rotate sites.
  • IV preparation may be given undiluted or added to standard compatible IV solutions.
  • Store all forms of drug at room temperature in tightly-closed, light-resistant containers. Avoid freezing injection.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Assess for signs of vitamin B6 deficiency (eg, irritability, seizures, anemia, dermatitis, nausea, vomiting) prior to and during therapy.
  • Institute seizure precautions in pyridoxine-dependent infants.
  • Obtain dietary consultation to review importance of well-balanced meals and sources of B6 prior to discharge home.
OVERDOSAGE: SIGNS & SYMPTOMS
  Ataxia, sensory neuropathy

 

Patient/Family Education

  • Emphasize importance of complying with prescribed dietary recommendations.
  • Teach patient about foods high in B6 (whole grain cereals, meat [eg, liver,] potatoes, green vegetables, legumes [eg, lima beans], yeast and bananas).
  • If patient is self-medicating with vitamin supplements, caution that megadosing may cause side effects such as unsteady gait, impaired hand coordination and numbness of feet.

Drug Mode of Action ::  

(peer-ih-DOX-een HIGH-droe-KLOR-ide)
Aminoxin, Nestrex,  Hexa-Betalin
Class: Vitamin

 

Action Vitamin B6 functions as coenzyme in amino acid, carbohydrate and lipid metabolism.

 

Indications Pyridoxine deficiency, including inadequate diet, drug-induced causes (eg, isoniazid, hydralazine, oral contraceptives) or inborn errors of metabolism. Parenteral use is indicated when oral therapy is not feasible. Unlabeled use(s): Treatment of hydrazine poisoning, PMS, hyperoxaluria type I, nausea and vomiting in pregnancy, sideroblastic anemia associated with high serum iron, carpal tunnel syndrome, tardive dyskinesia.

 

Contraindications Standard considerations.

 

Route/Dosage

Dietary Deficiency

ADULTS: PO/IM/IV 10 to 20 mg/day for 3 wk.

Drug-Induced Deficiency Anemia or Neuritis

ADULTS: PO/IM/IV 100 to 200 mg/day for 3 wk; follow with 25 to 100 mg/day.

Neuropathy

ADULTS: PO/IM/IV 50 to 200 mg/day.

Vitamin B6 Dependency Syndrome

ADULTS: PO/IM/IV 600 mg, followed by 30 mg/day for life. Dependency has been noted in adults administered 200 mg/day. PYRIDOXINE-DEPENDENT INFANTS: IM/IV 10 to 100 mg, followed by 2 to 100 mg/day.

Metabolic Disorders

ADULTS: PO/IM/IV 100 to 500 mg/day.

Isoniazid (INH) Poisoning

ADULTS & CHILDREN: IV 4 gm IV followed by 1 gm IM q 30 min until pyridoxine dose equal to INH dose has been given.

 

Interactions

Cycloserine, INH, hydralazine, oral contraceptives, penicillamine: Increased need for pyridoxine. Levodopa: Decreased effect of levodopa. (Interaction does not occur with levodopa/carbidopa in combination with pyridoxine.) Phenytoin: Phenytoin serum levels may be decreased. Parenteral: INCOMPATIBILITIES: Incompatible with alkaline solutions, iron salts and oxidizing agents.

 

Lab Test Interferences May result in false-positive urobilinogen in the spot test using Ehrlich’s reagent.

 

Adverse Reactions

CNS: Neuropathy; unstable gait; drowsiness; somnolence. EENT: Perioral numbness. OTHER: Numbness of feet; decreased sensation to touch, temperature or vibration; paresthesia; low serum folic acid levels; burning/stinging at IM injection site; photoallergic reaction; ataxia.

 

Precautions

Pregnancy: Category A. (Category C in doses that exceed the RDA.) Lactation: Excreted in breast milk; may inhibit lactation. Children: Safety and efficacy not established in doses exceeding nutritional requirements.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • Instruct patient to swallow sustained-release preparation whole and not to break, crush or chew.
  • When giving via IM route, rotate sites.
  • IV preparation may be given undiluted or added to standard compatible IV solutions.
  • Store all forms of drug at room temperature in tightly-closed, light-resistant containers. Avoid freezing injection.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Assess for signs of vitamin B6 deficiency (eg, irritability, seizures, anemia, dermatitis, nausea, vomiting) prior to and during therapy.
  • Institute seizure precautions in pyridoxine-dependent infants.
  • Obtain dietary consultation to review importance of well-balanced meals and sources of B6 prior to discharge home.
OVERDOSAGE: SIGNS & SYMPTOMS
  Ataxia, sensory neuropathy

 

Patient/Family Education

  • Emphasize importance of complying with prescribed dietary recommendations.
  • Teach patient about foods high in B6 (whole grain cereals, meat [eg, liver,] potatoes, green vegetables, legumes [eg, lima beans], yeast and bananas).
  • If patient is self-medicating with vitamin supplements, caution that megadosing may cause side effects such as unsteady gait, impaired hand coordination and numbness of feet.

Drug Interactions ::

(peer-ih-DOX-een HIGH-droe-KLOR-ide)
Aminoxin, Nestrex,  Hexa-Betalin
Class: Vitamin

 

Action Vitamin B6 functions as coenzyme in amino acid, carbohydrate and lipid metabolism.

 

Indications Pyridoxine deficiency, including inadequate diet, drug-induced causes (eg, isoniazid, hydralazine, oral contraceptives) or inborn errors of metabolism. Parenteral use is indicated when oral therapy is not feasible. Unlabeled use(s): Treatment of hydrazine poisoning, PMS, hyperoxaluria type I, nausea and vomiting in pregnancy, sideroblastic anemia associated with high serum iron, carpal tunnel syndrome, tardive dyskinesia.

 

Contraindications Standard considerations.

 

Route/Dosage

Dietary Deficiency

ADULTS: PO/IM/IV 10 to 20 mg/day for 3 wk.

Drug-Induced Deficiency Anemia or Neuritis

ADULTS: PO/IM/IV 100 to 200 mg/day for 3 wk; follow with 25 to 100 mg/day.

Neuropathy

ADULTS: PO/IM/IV 50 to 200 mg/day.

Vitamin B6 Dependency Syndrome

ADULTS: PO/IM/IV 600 mg, followed by 30 mg/day for life. Dependency has been noted in adults administered 200 mg/day. PYRIDOXINE-DEPENDENT INFANTS: IM/IV 10 to 100 mg, followed by 2 to 100 mg/day.

Metabolic Disorders

ADULTS: PO/IM/IV 100 to 500 mg/day.

Isoniazid (INH) Poisoning

ADULTS & CHILDREN: IV 4 gm IV followed by 1 gm IM q 30 min until pyridoxine dose equal to INH dose has been given.

 

Interactions

Cycloserine, INH, hydralazine, oral contraceptives, penicillamine: Increased need for pyridoxine. Levodopa: Decreased effect of levodopa. (Interaction does not occur with levodopa/carbidopa in combination with pyridoxine.) Phenytoin: Phenytoin serum levels may be decreased. Parenteral: INCOMPATIBILITIES: Incompatible with alkaline solutions, iron salts and oxidizing agents.

 

Drug Assesment ::

(peer-ih-DOX-een HIGH-droe-KLOR-ide)
Aminoxin, Nestrex,  Hexa-Betalin
Class: Vitamin

 

Action Vitamin B6 functions as coenzyme in amino acid, carbohydrate and lipid metabolism.

 

Indications Pyridoxine deficiency, including inadequate diet, drug-induced causes (eg, isoniazid, hydralazine, oral contraceptives) or inborn errors of metabolism. Parenteral use is indicated when oral therapy is not feasible. Unlabeled use(s): Treatment of hydrazine poisoning, PMS, hyperoxaluria type I, nausea and vomiting in pregnancy, sideroblastic anemia associated with high serum iron, carpal tunnel syndrome, tardive dyskinesia.

 

Contraindications Standard considerations.

 

Route/Dosage

Dietary Deficiency

ADULTS: PO/IM/IV 10 to 20 mg/day for 3 wk.

Drug-Induced Deficiency Anemia or Neuritis

ADULTS: PO/IM/IV 100 to 200 mg/day for 3 wk; follow with 25 to 100 mg/day.

Neuropathy

ADULTS: PO/IM/IV 50 to 200 mg/day.

Vitamin B6 Dependency Syndrome

ADULTS: PO/IM/IV 600 mg, followed by 30 mg/day for life. Dependency has been noted in adults administered 200 mg/day. PYRIDOXINE-DEPENDENT INFANTS: IM/IV 10 to 100 mg, followed by 2 to 100 mg/day.

Metabolic Disorders

ADULTS: PO/IM/IV 100 to 500 mg/day.

Isoniazid (INH) Poisoning

ADULTS & CHILDREN: IV 4 gm IV followed by 1 gm IM q 30 min until pyridoxine dose equal to INH dose has been given.

 

Interactions

Cycloserine, INH, hydralazine, oral contraceptives, penicillamine: Increased need for pyridoxine. Levodopa: Decreased effect of levodopa. (Interaction does not occur with levodopa/carbidopa in combination with pyridoxine.) Phenytoin: Phenytoin serum levels may be decreased. Parenteral: INCOMPATIBILITIES: Incompatible with alkaline solutions, iron salts and oxidizing agents.

 

Lab Test Interferences May result in false-positive urobilinogen in the spot test using Ehrlich’s reagent.

 

Adverse Reactions

CNS: Neuropathy; unstable gait; drowsiness; somnolence. EENT: Perioral numbness. OTHER: Numbness of feet; decreased sensation to touch, temperature or vibration; paresthesia; low serum folic acid levels; burning/stinging at IM injection site; photoallergic reaction; ataxia.

 

Precautions

Pregnancy: Category A. (Category C in doses that exceed the RDA.) Lactation: Excreted in breast milk; may inhibit lactation. Children: Safety and efficacy not established in doses exceeding nutritional requirements.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • Instruct patient to swallow sustained-release preparation whole and not to break, crush or chew.
  • When giving via IM route, rotate sites.
  • IV preparation may be given undiluted or added to standard compatible IV solutions.
  • Store all forms of drug at room temperature in tightly-closed, light-resistant containers. Avoid freezing injection.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Assess for signs of vitamin B6 deficiency (eg, irritability, seizures, anemia, dermatitis, nausea, vomiting) prior to and during therapy.
  • Institute seizure precautions in pyridoxine-dependent infants.
  • Obtain dietary consultation to review importance of well-balanced meals and sources of B6 prior to discharge home.
OVERDOSAGE: SIGNS & SYMPTOMS
  Ataxia, sensory neuropathy

 

Patient/Family Education

  • Emphasize importance of complying with prescribed dietary recommendations.
  • Teach patient about foods high in B6 (whole grain cereals, meat [eg, liver,] potatoes, green vegetables, legumes [eg, lima beans], yeast and bananas).
  • If patient is self-medicating with vitamin supplements, caution that megadosing may cause side effects such as unsteady gait, impaired hand coordination and numbness of feet.

Drug Storage/Management ::

(peer-ih-DOX-een HIGH-droe-KLOR-ide)
Aminoxin, Nestrex,  Hexa-Betalin
Class: Vitamin

 

Action Vitamin B6 functions as coenzyme in amino acid, carbohydrate and lipid metabolism.

 

Indications Pyridoxine deficiency, including inadequate diet, drug-induced causes (eg, isoniazid, hydralazine, oral contraceptives) or inborn errors of metabolism. Parenteral use is indicated when oral therapy is not feasible. Unlabeled use(s): Treatment of hydrazine poisoning, PMS, hyperoxaluria type I, nausea and vomiting in pregnancy, sideroblastic anemia associated with high serum iron, carpal tunnel syndrome, tardive dyskinesia.

 

Contraindications Standard considerations.

 

Route/Dosage

Dietary Deficiency

ADULTS: PO/IM/IV 10 to 20 mg/day for 3 wk.

Drug-Induced Deficiency Anemia or Neuritis

ADULTS: PO/IM/IV 100 to 200 mg/day for 3 wk; follow with 25 to 100 mg/day.

Neuropathy

ADULTS: PO/IM/IV 50 to 200 mg/day.

Vitamin B6 Dependency Syndrome

ADULTS: PO/IM/IV 600 mg, followed by 30 mg/day for life. Dependency has been noted in adults administered 200 mg/day. PYRIDOXINE-DEPENDENT INFANTS: IM/IV 10 to 100 mg, followed by 2 to 100 mg/day.

Metabolic Disorders

ADULTS: PO/IM/IV 100 to 500 mg/day.

Isoniazid (INH) Poisoning

ADULTS & CHILDREN: IV 4 gm IV followed by 1 gm IM q 30 min until pyridoxine dose equal to INH dose has been given.

 

Interactions

Cycloserine, INH, hydralazine, oral contraceptives, penicillamine: Increased need for pyridoxine. Levodopa: Decreased effect of levodopa. (Interaction does not occur with levodopa/carbidopa in combination with pyridoxine.) Phenytoin: Phenytoin serum levels may be decreased. Parenteral: INCOMPATIBILITIES: Incompatible with alkaline solutions, iron salts and oxidizing agents.

 

Lab Test Interferences May result in false-positive urobilinogen in the spot test using Ehrlich’s reagent.

 

Adverse Reactions

CNS: Neuropathy; unstable gait; drowsiness; somnolence. EENT: Perioral numbness. OTHER: Numbness of feet; decreased sensation to touch, temperature or vibration; paresthesia; low serum folic acid levels; burning/stinging at IM injection site; photoallergic reaction; ataxia.

 

Precautions

Pregnancy: Category A. (Category C in doses that exceed the RDA.) Lactation: Excreted in breast milk; may inhibit lactation. Children: Safety and efficacy not established in doses exceeding nutritional requirements.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • Instruct patient to swallow sustained-release preparation whole and not to break, crush or chew.
  • When giving via IM route, rotate sites.
  • IV preparation may be given undiluted or added to standard compatible IV solutions.
  • Store all forms of drug at room temperature in tightly-closed, light-resistant containers. Avoid freezing injection.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Assess for signs of vitamin B6 deficiency (eg, irritability, seizures, anemia, dermatitis, nausea, vomiting) prior to and during therapy.
  • Institute seizure precautions in pyridoxine-dependent infants.
  • Obtain dietary consultation to review importance of well-balanced meals and sources of B6 prior to discharge home.
OVERDOSAGE: SIGNS & SYMPTOMS
  Ataxia, sensory neuropathy

 

Patient/Family Education

  • Emphasize importance of complying with prescribed dietary recommendations.
  • Teach patient about foods high in B6 (whole grain cereals, meat [eg, liver,] potatoes, green vegetables, legumes [eg, lima beans], yeast and bananas).
  • If patient is self-medicating with vitamin supplements, caution that megadosing may cause side effects such as unsteady gait, impaired hand coordination and numbness of feet.

Drug Notes ::

(peer-ih-DOX-een HIGH-droe-KLOR-ide)
Aminoxin, Nestrex,  Hexa-Betalin
Class: Vitamin

 

Action Vitamin B6 functions as coenzyme in amino acid, carbohydrate and lipid metabolism.

 

Indications Pyridoxine deficiency, including inadequate diet, drug-induced causes (eg, isoniazid, hydralazine, oral contraceptives) or inborn errors of metabolism. Parenteral use is indicated when oral therapy is not feasible. Unlabeled use(s): Treatment of hydrazine poisoning, PMS, hyperoxaluria type I, nausea and vomiting in pregnancy, sideroblastic anemia associated with high serum iron, carpal tunnel syndrome, tardive dyskinesia.

 

Contraindications Standard considerations.

 

Route/Dosage

Dietary Deficiency

ADULTS: PO/IM/IV 10 to 20 mg/day for 3 wk.

Drug-Induced Deficiency Anemia or Neuritis

ADULTS: PO/IM/IV 100 to 200 mg/day for 3 wk; follow with 25 to 100 mg/day.

Neuropathy

ADULTS: PO/IM/IV 50 to 200 mg/day.

Vitamin B6 Dependency Syndrome

ADULTS: PO/IM/IV 600 mg, followed by 30 mg/day for life. Dependency has been noted in adults administered 200 mg/day. PYRIDOXINE-DEPENDENT INFANTS: IM/IV 10 to 100 mg, followed by 2 to 100 mg/day.

Metabolic Disorders

ADULTS: PO/IM/IV 100 to 500 mg/day.

Isoniazid (INH) Poisoning

ADULTS & CHILDREN: IV 4 gm IV followed by 1 gm IM q 30 min until pyridoxine dose equal to INH dose has been given.

 

Interactions

Cycloserine, INH, hydralazine, oral contraceptives, penicillamine: Increased need for pyridoxine. Levodopa: Decreased effect of levodopa. (Interaction does not occur with levodopa/carbidopa in combination with pyridoxine.) Phenytoin: Phenytoin serum levels may be decreased. Parenteral: INCOMPATIBILITIES: Incompatible with alkaline solutions, iron salts and oxidizing agents.

 

Lab Test Interferences May result in false-positive urobilinogen in the spot test using Ehrlich’s reagent.

 

Adverse Reactions

CNS: Neuropathy; unstable gait; drowsiness; somnolence. EENT: Perioral numbness. OTHER: Numbness of feet; decreased sensation to touch, temperature or vibration; paresthesia; low serum folic acid levels; burning/stinging at IM injection site; photoallergic reaction; ataxia.

 

Precautions

Pregnancy: Category A. (Category C in doses that exceed the RDA.) Lactation: Excreted in breast milk; may inhibit lactation. Children: Safety and efficacy not established in doses exceeding nutritional requirements.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • Instruct patient to swallow sustained-release preparation whole and not to break, crush or chew.
  • When giving via IM route, rotate sites.
  • IV preparation may be given undiluted or added to standard compatible IV solutions.
  • Store all forms of drug at room temperature in tightly-closed, light-resistant containers. Avoid freezing injection.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Assess for signs of vitamin B6 deficiency (eg, irritability, seizures, anemia, dermatitis, nausea, vomiting) prior to and during therapy.
  • Institute seizure precautions in pyridoxine-dependent infants.
  • Obtain dietary consultation to review importance of well-balanced meals and sources of B6 prior to discharge home.
OVERDOSAGE: SIGNS & SYMPTOMS
  Ataxia, sensory neuropathy

 

Patient/Family Education

  • Emphasize importance of complying with prescribed dietary recommendations.
  • Teach patient about foods high in B6 (whole grain cereals, meat [eg, liver,] potatoes, green vegetables, legumes [eg, lima beans], yeast and bananas).
  • If patient is self-medicating with vitamin supplements, caution that megadosing may cause side effects such as unsteady gait, impaired hand coordination and numbness of feet.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.